• About us
• Contact

Advertisement

Organisation › Details

Encodia Inc.

Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enables highly scalable protein analysis via an accessible and easy-to-use benchtop instrument. Tools employing Encodia’s ProteoCode technology will drive new biological understanding with impact in data-driven drug discovery and development, new high complexity diagnostics, and beyond. *

 

	Start	2018-11-11 existent
	Industry	proteomic technology
	Industry 2	ProteoCode™ technology
	Person	Chee, Mark (Encodia 202101 President + Co-Founder before Prognosys Biosciences + Affymetrix + Illumina)
	Region	San Diego, CA
	Country	United States (USA)
	Street	11045 Roselle Street Suite #120
	City	92121 San Diego, CA
		Address record changed: 2021-02-07
Basic data	Employees	n. a.
		* Document for »About Section«: Encodia, Inc.. (1/26/21). "Press Release: Encodia Closes $75M Series C Financing Led by Northpond Ventures and Deerfield Management". San Diego, CA.
		Record changed: 2023-07-10

Advertisement

More documents for Encodia Inc.

• [1] Encodia, Inc.. (1/26/21). "Press Release: Encodia Closes $75M Series C Financing Led by Northpond Ventures and Deerfield Management". San Diego, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.